Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ: IMDX · Real-Time Price · USD
4.340
-0.090 (-2.03%)
Aug 12, 2026, 3:44 PM EDT - Market open
IMDX Market Cap
IMDX has a market cap or net worth of $140.14 million as of August 12, 2026. Its market cap has increased by 87.60% in one year.
Market Cap
140.14M
Enterprise Value
125.01M
1-Year Change
87.60%
Ranking
Category
Stock Price
$4.34
ChartMarket Cap Chart
Since January 4, 2016, IMDX's market cap has decreased from $228.70M to $140.14M, a decrease of -38.72%. That is a compound annual growth rate of -4.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 140.14M | -34.82% |
| Dec 31, 2025 | 215.00M | 436.16% |
| Dec 31, 2024 | 40.10M | 93.72% |
| Dec 29, 2023 | 20.70M | -45.67% |
| Dec 30, 2022 | 38.10M | -80.96% |
| Dec 31, 2021 | 200.10M | 24.52% |
| Dec 31, 2020 | 160.70M | 37.47% |
| Dec 31, 2019 | 116.90M | 108.38% |
| Dec 31, 2018 | 56.10M | -61.60% |
| Dec 29, 2017 | 146.10M | -27.82% |
| Dec 30, 2016 | 202.40M | -11.50% |
| Jan 4, 2016 | 228.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Freenome | 1.35B |
| OPKO Health | 1.04B |
| Castle Biosciences | 984.92M |
| Fulgent Genetics | 522.79M |
| Myriad Genetics | 307.99M |
| Biodesix | 256.50M |
| Exagen | 164.01M |
| Quantum Cyber | 115.17M |